(Q39168114)

9 September 2017

title

The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules (English)

1 reference

9 September 2017

0 references

Harshini Mudaliar

1

1 reference

9 September 2017

Carol Pollock

2

1 reference

9 September 2017

Muralikrishna Gangadharan Komala

3

1 reference

9 September 2017

Steven Chadban

4

1 reference

9 September 2017

Huiling Wu

5

1 reference

9 September 2017

Usha Panchapakesan

6

1 reference

9 September 2017

language of work or name

1 reference

10 April 2013

1 reference

American Journal of Physiology - Renal Physiology

9 September 2017

published in

1 reference

9 September 2017

volume

305

1 reference

9 September 2017

issue

2

1 reference

9 September 2017

page(s)

F143-54

1 reference

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

The extracellular release of HMGB1 during apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

The role of high-mobility group box-1 in renal ischemia and reperfusion injury and the effect of ethyl pyruvate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Relevance of Toll-like receptor-4 polymorphisms in renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Endogenous ligands of TLR2 and TLR4: agonists or assistants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

RAAS inhibition and renal protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

The role of Toll-like receptors in renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

HMGB1: endogenous danger signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Increased expression of toll-like receptor 2 in rat diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Inflammation and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

HMGB1 is an endogenous immune adjuvant released by necrotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Impact of Toll-like receptor signalling on urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Chronic kidney disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

HMGB1 contributes to kidney ischemia reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

Mammalian toll-like receptors: from endogenous ligands to tissue regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00398.2012

10.1152/AJPRENAL.00398.2012

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference